Endocrinology (all articles)
Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.
28 Jan, 2022 | 08:05h | UTC
Perspective: From vaginal laser treatment to spa breaks – it’s the great menopause gold rush.
27 Jan, 2022 | 09:36h | UTCFrom vaginal laser treatment to spa breaks – it’s the great menopause gold rush – The Guardian
ESC Position Statement: Cardiovascular effects of doping substances, commonly prescribed medications, and ergogenic aids in relation to sports.
27 Jan, 2022 | 09:43h | UTCNews Release: Athletes warned against potential dangers of natural supplements – European Society of Cardiology
Short-term glucocorticoid-related side effects and adverse reactions: a narrative review and practical approach.
27 Jan, 2022 | 09:18h | UTC
Long-term results of RCT: GH replacement with once-weekly somapacitan is comparable to daily GH in children with growth hormone deficiency.
25 Jan, 2022 | 09:07h | UTC
Clinical review of subcutaneous Semaglutide for obesity.
24 Jan, 2022 | 07:54h | UTC
RCT: In very young children with Type 1 Diabetes, a hybrid closed-loop therapy (“artificial pancreas”) resulted in better glycemic control without increased risk of hypoglycemia vs. sensor-augmented pump therapy.
20 Jan, 2022 | 09:07h | UTCRandomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes – New England Journal of Medicine (link to abstract – $ for full-text)
Consensus Statement: Exercise/physical activity in individuals with Type 2 Diabetes.
20 Jan, 2022 | 08:51h | UTC
Commentary from the author on Twitter
Exercise/Physical Activity in Individuals with
Type 2 Diabetes: A Consensus Statement from
the American College of Sports Medicine
Honored to contribute w/several esteemed colleagues to this report now out on #exercise & #diabetes @MSSEonline @ACSMNews https://t.co/UNmoU2BgLR— Juleen R. Zierath (@JuleenRZierath) January 14, 2022
Review: Diagnosis and treatment of polycystic ovary syndrome.
20 Jan, 2022 | 08:54h | UTCDiagnosis and Treatment of Polycystic Ovary Syndrome – JAMA (free for a limited period)
M-A: Association of Sodium-Glucose Cotransporter 2 Inhibitors with cardiovascular outcomes in patients with Type 2 Diabetes and other risk factors for cardiovascular disease.
20 Jan, 2022 | 08:42h | UTC
Commentary on Twitter
This meta-analysis found that use of SGLT2-Is was associated with lower occurrence of cardiovascular death or hospitalization for heart failure by 33% in high-risk patients. @mukul_bhattarai @AkcharAl @AbhiKulk82 @mominsiddique01 @Mohsin_Salih19 https://t.co/omPP6Qwofg
— JAMA Network Open (@JAMANetworkOpen) January 5, 2022
Association of hormonal contraceptive use with adverse health outcomes: an umbrella review of meta-analyses of randomized clinical trials and cohort studies.
18 Jan, 2022 | 09:29h | UTC
Cohort study: In patients who underwent bariatric surgery, those submitted to gastric bypass were slightly more likely to remain free of obesity-related medications during follow-up compared with those who underwent sleeve gastrectomy.
18 Jan, 2022 | 09:31h | UTCMedication Use for Obesity-Related Comorbidities After Sleeve Gastrectomy or Gastric Bypass – JAMA Surgery (link to abstract – $ for full-text)
Commentary: Gastric Bypass Tied to Modest Shift in Need for Comorbidity Meds – MedPage Today (free registration required)
Commentary on Twitter
Among patients taking medications for obesity-related conditions before bariatric surgery, gastric bypass and sleeve gastrectomy both had high rates of medication discontinuation after surgery, however gastric bypass was slightly more effective. https://t.co/JrIaYk9dZT pic.twitter.com/BAbaGINCpb
— JAMA Surgery (@JAMASurgery) January 12, 2022
Treating Acne in Transgender Persons Receiving Testosterone: A Practical Guide.
18 Jan, 2022 | 09:23h | UTC
RCT: Oral Vitamin D supplementation (60.000 IU per month) did not reduce mortality in patients 60 years or older (unscreened individuals in Australia, many without insufficiency, average 30ng/mL). Exploratory analyses pointed towards an increased risk of death from cancer.
16 Jan, 2022 | 23:13h | UTCThe D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)
Related:
Randomized Trial: Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease
Meta-Analysis: Vitamin D Not Effective for Cardiovascular Disease Prevention
Vitamin D, calcium, other vitamins, and supplements do not prevent cardiovascular diseases
Research: Circulating vitamin D concentration and risk of seven cancers
Research: Vitamin D and risk of total and site specific cancers
ERAS Guidelines for perioperative care in bariatric surgery.
16 Jan, 2022 | 23:21h | UTCRelated: Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines
Commentary on Twitter
#VisualAbstract ➡️ Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations: A 2021 Update@Jasosamd @iss_sic
🆓🔗https://t.co/HknWwLUjCZ pic.twitter.com/amhszadwup— World Journal of Surgery (@WorldJSurg) January 5, 2022
RCT: Vitamin D supplementation is not beneficial for the prevention of cardiovascular disease and cancer.
16 Jan, 2022 | 23:11h | UTCNews Release: Five years of high-dose vitamin D did not affect incidence of cardiovascular disease or cancer – University of Eastern Finland
Related:
Randomized Trial: Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease
Meta-Analysis: Vitamin D Not Effective for Cardiovascular Disease Prevention
Vitamin D, calcium, other vitamins, and supplements do not prevent cardiovascular diseases
Research: Circulating vitamin D concentration and risk of seven cancers
Research: Vitamin D and risk of total and site specific cancers
Perspective: Primary care providers should prescribe aspirin to prevent cardiovascular disease based on benefit−risk ratio, not age.
16 Jan, 2022 | 22:53h | UTCCommentaries:
Researchers urge: ‘Prescribe aspirin based on benefit-to-risk not age’ – Florida Atlantic University
Preventive Aspirin Should Be Based on Benefit, Not Age – HealthDay
Assessment and treatment of thyroid disorders in pregnancy and the postpartum period.
16 Jan, 2022 | 22:42h | UTCAssessment and treatment of thyroid disorders in pregnancy and the postpartum period – Nature Reviews Endocrinology (if the link is paywalled, try this one)
Commentary on Twitter
New content online: Assessment and treatment of thyroid disorders in pregnancy and the postpartum period https://t.co/KrXeocu8sd pic.twitter.com/HeSCXNkelb
— Nature Reviews Endocrinology (@NatureRevEndo) January 4, 2022
RCT: In patients with acromegaly who previously tolerated and responded to both regimens, oral octreotide was non-inferior for maintaining biochemical response and symptomatic control compared to injectable somatostatin receptor ligands.
14 Jan, 2022 | 07:55h | UTCMaintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)
The year in cardiovascular medicine 2021: diabetes and metabolic disorders.
13 Jan, 2022 | 08:33h | UTCThe year in cardiovascular medicine 2021: diabetes and metabolic disorders – European Heart Journal
The year in cardiovascular medicine 2021: dyslipidemia.
13 Jan, 2022 | 08:30h | UTCThe year in cardiovascular medicine 2021: dyslipidemia – European Heart Journal
M-A: Intermittent Fasting and Obesity-Related Health Outcomes.
13 Jan, 2022 | 08:22h | UTC
RCT: High-dose weekly Semaglutide (2.4 mg) resulted in increased weight loss compared to daily Liraglutide (3.0 mg).
12 Jan, 2022 | 08:55h | UTCEffect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial – JAMA (free for a limited period)
Commentary on Twitter
In this randomized clinical trial of 338 participants, mean body weight change from baseline to 68 weeks was –15.8% with semaglutide vs –6.4% with liraglutide, a statistically significant difference. https://t.co/8tktjqw4mE pic.twitter.com/BxrL1XPpKv
— JAMA (@JAMA_current) January 11, 2022
Cohort Study: Higher consumption of olive oil linked to lower risk of cardiovascular, cancer, and all-cause mortality.
12 Jan, 2022 | 08:41h | UTCConsumption of Olive Oil and Risk of Total and Cause-Specific Mortality Among U.S. Adults – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Commentaries:
Higher olive oil intake associated with lower risk of CVD mortality – American College of Cardiology
AHA Scientific Statement: Comprehensive management of cardiovascular risk factors for adults with Type 2 Diabetes.
11 Jan, 2022 | 02:40h | UTC